NCT06245187

Brief Summary

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17,198

participants targeted

Target at P75+ for all trials

Timeline
166mo left

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Jan 2013Jan 2040

Study Start

First participant enrolled

January 1, 2013

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

February 23, 2016

Completed
8 years until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
15.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2040

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2040

Last Updated

January 29, 2025

Status Verified

January 1, 2024

Enrollment Period

27 years

First QC Date

February 23, 2016

Last Update Submit

January 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac Tamponade and/or Pericardiocentesis Following Ablation

    Percent of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days following ablation procedure.

    30 days

Interventions

Evidence based recommended therapies and counseling prior to hospital discharge.

Eligibility Criteria

Age18 Years - 125 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population is patients with the diagnosis of nonvalvular Atrial Fibrillation or Atrial Flutter.

You may qualify if:

  • Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

You may not qualify if:

  • Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
  • Patients under 18 years of age
  • Patients not admitted as inpatients.
  • Patients on comfort care only
  • Patients discharged to hospice.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amy Bennett

Dallas, Texas, 75231, United States

RECRUITING

Related Publications (1)

  • January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28. No abstract available.

    PMID: 24685669BACKGROUND

MeSH Terms

Conditions

Atrial FibrillationAtrial Flutter

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Javed Butler, MD

    American Heart Association

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amy Bennett, JD

CONTACT

Christine Rutan

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
3 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2016

First Posted

February 7, 2024

Study Start

January 1, 2013

Primary Completion (Estimated)

January 1, 2040

Study Completion (Estimated)

January 1, 2040

Last Updated

January 29, 2025

Record last verified: 2024-01

Locations